(Q36308987)

13 August 2017

Lamivudine does not increase the efficacy of interferon in the treatment of mutant type chronic viral hepatitis B. (English)

1 reference

13 August 2017

1 reference

1 reference

Sien-Sing Yang

1

1 reference

13 August 2017

Chao-Tien Hsu

2

1 reference

13 August 2017

Jui-Ting Hu

3

1 reference

13 August 2017

Yung-Chih Lai

4

1 reference

13 August 2017

Chi-Hwa Wu

5

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

World Journal of Gastroenterology

13 August 2017

1 reference

13 August 2017

8

1 reference

13 August 2017

5

1 reference

13 August 2017

868-871

1 reference

Hepatitis B e antigen seroconversion: effects of lamivudine alone or in combination with interferon alpha

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4656577

Viruses and hepatocellular carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4656577

Long-term outcome of interferon-alpha therapy for chronic hepatitis B

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4656577

Hepatitis B virus precore/core variation and interferon therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4656577

Long-term effect of interferon therapy in chronic hepatitis B.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4656577

Treatment of chronic hepatitis B with interferon: experience in western countries

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4656577

Hepatitis B: Evolving Epidemiology and Implications for Control

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4656577

The treatment of chronic viral hepatitis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4656577

Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4656577

Long-term therapy of chronic hepatitis B with lamivudine.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4656577

Combined interferon and lamivudine therapy: is this the treatment of choice for patients with chronic hepatitis B virus infection?

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4656577

Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4656577

Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen-negative chronic hepatitis B.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4656577

A pilot study of ribavirin and interferon beta for the treatment of chronic hepatitis C.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4656577

Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4656577

Interferon treatment in patients with chronic hepatitis B: A meta-analysis of the published literature

21 October 2018

1 reference

Crossref

https://api.crossref.org/works/10.3748%2FWJG.V8.I5.868

HBV precore mutants and response to interferon

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12378632

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

New nucleoside analogues for chronic hepatitis B

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12378632

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A preliminary trial of lamivudine for chronic hepatitis B infection

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12378632

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3748/WJG.V8.I5.868

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

12378632

1 reference